Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121108
Status:
COMPLETED
Last Update Posted:
2022-01-05
First Post:
2005-07-13
Brief Title:
MEDI-524 Motavizumab for the Prevention of Respiratory Sycytial Virus RSV Disease Among Native American Indian Infants in the Southwestern United States
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2010-12-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12-27
Completion Date Type:
ACTUAL
First Submit Date:
2005-07-13
First Submit QC Date:
July 19 2005
Study First Post Date:
2005-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-01-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2012-03-08
Disp First Submit QC Date:
June 27 2012
Disp First Post Date:
2012-07-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-12-07
Last Update Post Date:
2022-01-05
Last Update Post Date Type:
ACTUAL